Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX)
$6.9100
-0.3500 ( -1.99% ) 8.3M
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Market Data
Open
$6.9100
Previous close
$7.2600
Volume
8.3M
Market cap
$2.73B
Day range
$6.7860 - $7.4690
52 week range
$5.6000 - $15.7400
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Aug 19, 2024 |
4 | Insider transactions | 1 | Aug 19, 2024 |
4 | Insider transactions | 1 | Aug 19, 2024 |
4 | Insider transactions | 1 | Aug 15, 2024 |
4 | Insider transactions | 1 | Aug 09, 2024 |
8-k | 8K-related | 135 | Aug 08, 2024 |
4 | Insider transactions | 1 | Aug 08, 2024 |
10-q | Quarterly Reports | 80 | Aug 08, 2024 |
8-k | 8K-related | 13 | Aug 06, 2024 |
4 | Insider transactions | 1 | Aug 05, 2024 |